M&A

GM and Isuzu form new joint venture to boost Chevrolet sales in Colombia

12 May 2008

US bank Sovereign looking to raise $1.5 billion; may lose management control to Santander

10 May 2008

ArcelorMittal files suit against Esmark / E2 over failed Sparrows Point sale

10 May 2008

Bharti closer to $20-billion MTN deal as major shareholder Mikati expresses confidence

10 May 2008

Former Lebanese prime minister Najib Mikati's London-based MI Group, a major shareholder in MTN, is reported to have expressed confidenc in Sunil Mittal's proposed acquisition of the African and Middle East telecom operator MTN.

Jubilant Organosys acquires Speciality Molecules for about Rs20 crore

08 May 2008

Adlabs acquires majority stake in Malaysian cinema chain

06 May 2008

HSBC gets more time to acquire Lone Star stake in Korea Exchange Bank

29 Apr 2008

3i Infotech to acquire largest independent remittance provider Regulus Group

29 Apr 2008

Tata Power refinances bridge loan taken for acquisition of 30 per cent stake in Indonesian coal miners Kaltim, Arutmin

29 Apr 2008

New York Daily News owner matches Murdoch's $580 offer for Newsday

26 Apr 2008

Shaw Wallace shareholders approve merger with United Spirits

25 Apr 2008

Cabinet approves Bharat Refractories merger with SAIL

25 Apr 2008

Berlusconi promises rescue - and also job cuts - at Alitalia

24 Apr 2008

Bombay Rayon to acquire `Guru' brand in Italy for €33 million

24 Apr 2008

GlaxoSmithKline acquires Sirtris Pharmaceuticals

24 Apr 2008

Private equity firm TPG divests leather products maker Bally

23 Apr 2008

General Electric CEO resists calls to sell of company units in face of record losses

23 Apr 2008

Biocon close to finalising AxiCorp acquisition; establishes cardiology division

22 Apr 2008

Global M&As cross 11,000 deals valued at with $1 trillion in Q1 2008

21 Apr 2008

1 June 2008 to be cut-off date for Kingfisher-Deccan merger

21 Apr 2008

Dabur Pharma to sell majority stake to Singapore-based Fresenius Kabi Pte Ltd

19 Apr 2008

In a surprising development contrary to their recent stated stance on foreign collaboration, the promoters of home-grown anti-cancer drug maker Dabur Pharma have announced plans to sell a majority stake in the company to a Songapore-based firm.